CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoSCOTLANDI, KATIA
Dettaglio
SCOTLANDI, KATIA
Personale esterno ed autonomi
Pubblicazioni
Risultati 1 - 20 di 37 (tempo di esecuzione: 0.0 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
|---|---|---|---|---|---|---|---|
| 1 | Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS | Mattioli, Elisabetta; Andrenacci, Davide; Garofalo, Cecilia; Prencipe, Sabino; Scotlandi, Katia; ...Remondini, Daniel; Gentilini, Davide; Di Blasio, Anna Maria; Valente, Sergio; Scarano, Emanuela; Cicchilitti, Lucia; Piaggio, Giulia; Mai, Antonello; Lattanzi, Giovanna | 2018 | AGING CELL | 1.01 Articolo in rivista | ||
| 2 | Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines. | Zucchini C.; Rocchi A.; Manara M.C.; De Sanctis P.; Capanni C.; Bianchini M.; Carinci P.; Scotlan...di K.; Valvassori L. | 2008 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1.01 Articolo in rivista | - | |
| 3 | An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas. | Guerzoni C;Amatori S;Giorgi L;Manara MC;Landuzzi L;Lollini PL;Tassoni A;Balducci M;Manfrini M;Pra...telli L;Serra M;Picci P;Magnani M;Fusi V;Fanelli M;Scotlandi K | 2014 | BMC CANCER | 1.01 Articolo in rivista | ||
| 4 | Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). | D. Zambelli; M. Zuntini; F. Nardi; M.C. Manara; M. Serra; L. Landuzzi; P.-L. Lollini; S. Ferrari;... M. Alberghini; A. Llombart-Bosch; E. Piccolo; S. Iacobelli; P. Picci; K. Scotlandi. | 2010 | INTERNATIONAL JOURNAL OF CANCER | 1.01 Articolo in rivista | - | |
| 5 | Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations | Nanni, Patrizia; Landuzzi, Lorena; Manara, Maria Cristina; Righi, Alberto; Nicoletti, Giordano; C...ristalli, Camilla; Pasello, Michela; Parra, Alessandro; Carrabotta, Marianna; Ferracin, Manuela; Palladini, Arianna; Ianzano, Marianna L; Giusti, Veronica; Ruzzi, Francesca; Magnani, Mauro; Donati, Davide Maria; Picci, Piero; Lollini, Pier-Luigi; Scotlandi, Katia | 2019 | SCIENTIFIC REPORTS | 1.01 Articolo in rivista | ||
| 6 | Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling | Cantiani L.; Manara M.C.; Zucchini C.; De Sanctis P.; Zuntini M.; Valvassori L.; Serra M.; Oliver...o M.; Di Renzo M.F.; Colombo M.P.; Picci P.; Scotlandi K. | 2007 | CANCER RESEARCH | 1.01 Articolo in rivista | - | |
| 7 | CD99 Acts as an Oncosuppressor in Osteosarcoma. | Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.;... Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K. | 2006 | MOLECULAR BIOLOGY OF THE CELL | 1.01 Articolo in rivista | - | |
| 8 | CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. | Sciandra M;Marino MT;Manara MC;Guerzoni C;Grano M;Oranger A;Lucarelli E;Lollini PL;Dozza B;Pratel...li L;Renzo MF;Colombo MP;Picci P;Scotlandi K | 2014 | JOURNAL OF BONE AND MINERAL RESEARCH | 1.01 Articolo in rivista | - | |
| 9 | CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity | Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni ...P; Lollini PL; Bernard A; Picci P | 2007 | ONCOGENE | 1.01 Articolo in rivista | - | |
| 10 | CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. | Zucchini C;Manara MC;Pinca RS;De Sanctis P;Guerzoni C;Sciandra M;Lollini PL;Cenacchi G;Picci P;Va...lvassori L;Scotlandi K | 2014 | ONCOGENE | 1.01 Articolo in rivista | - | |
| 11 | Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells. | Dozza B.; Papi A.; Lucarelli E.; Scotlandi K.; Pierini M.; Tresca G.; Donati D.; Orlandi M. | 2012 | TOXICOLOGY IN VITRO | 1.01 Articolo in rivista | - | |
| 12 | Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications | Amaral, A.T.A.; Manara, M.C.; Berghuis, D.; Ordonez, J.L.; Biscuola, M.; Lopez-Garcia, M.A.; Osun...a, D.; Lucarelli, E.; Alviano, F.; Lankester, A.; Scotlandi, K.; De Alava, E. | 2014 | PLOS ONE | 1.01 Articolo in rivista | ||
| 13 | Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? | Emanuela Palmerini; Michela Pasello; Robin Lewis Jones; Maria Cristina Manara; Alessandro Parra; ...Piero Picci; Giovanni Grignani; Emanuela Marchesi; Marilena Cesari; Alessandra Longhi; Massimo Abate; Anna Paioli; Lorenzo D'Ambrosio; Franca Fagioli; Asaftei sebastian Dorin; Stefano Ferrari; Katia Scotlandi | 2017 | JOURNAL OF CLINICAL ONCOLOGY | 4.03 Poster | - | |
| 14 | Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation | De Feo A.; Sciandra M.; Ferracin M.; Felicetti F.; Astolfi A.; Pignochino Y.; Picci P.; Care A.; ...Scotlandi K. | 2019 | CELL DEATH & DISEASE | 1.01 Articolo in rivista | ||
| 15 | Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. | Contaldo C;Myers TJ;Zucchini C;Manara MC;Chiodoni C;Colombo MP;Nicoletti G;Lollini PL;Li T;Longob...ardi L;Scotlandi K;Spagnoli A | 2014 | GROWTH FACTORS | 1.01 Articolo in rivista | - | |
| 16 | High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy | P. Nanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Murgo; A. Palladini; A. Antognoli; M.L. Ianzano...; V. Stivani; V. Grosso; S.-M. Maira; C. García-Echeverría; K. Scotlandi; C. De Giovanni; P.-L. Lollini | 2010 | EUROPEAN JOURNAL OF CANCER | 1.01 Articolo in rivista | - | |
| 17 | Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene | ZUCCHINI C.; BIANCHINI M.; VALVASSORI L.; PERDICHIZZI S.; BENINI S.; MANARA MC.; SOLMI R.; STRIPP...OLI P.; PICCI P.; CARINCI P.; SCOTLANDI K. | 2004 | BONE | 1.01 Articolo in rivista | - | |
| 18 | Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma | Garofalo, Cecilia; Mancarella, Caterina; Grilli, Andrea; Manara, MARIA CRISTINA; Astolfi, Annalis...a; Marino, Maria Teresa; Conte, Alexia; Sigismund, Sara; Carã, Alessandra; Belfiore, Antonino; Picci, Piero; Scotlandi, Katia | 2012 | MOLECULAR ENDOCRINOLOGY | 1.01 Articolo in rivista | - | |
| 19 | Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. | Emanuela Palmerini; Claudio Agostinelli; Piero Picci; Stefano A Pileri; Pier-Luigi Lollini; Katia... Scotlandi; Maria Serena Benassi; Teresa Marafioti; Stefano Ferrari | 2017 | 4.03 Poster | - | ||
| 20 | Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy | Mancarella, Caterina; Pasello, Michela; Ventura, Selena; Grilli, Andrea; Calzolari, Linda; Toracc...hio, Lisa; Lollini, Pier Luigi; Donati, Davide Maria; Picci, Piero; Ferrari, Stefano; Scotlandi, Katia | 2018 | CLINICAL CANCER RESEARCH | 1.01 Articolo in rivista | - |
Copyright © 2020